2022
DOI: 10.3389/fmicb.2022.906103
|View full text |Cite
|
Sign up to set email alerts
|

Encapsulation of Salmonella phage SL01 in alginate/carrageenan microcapsules as a delivery system and its application in vitro

Abstract: Phages can be used successfully to treat pathogenic bacteria including zoonotic pathogens that colonize the intestines of animals and humans. However, low pH and digestive enzyme activity under harsh gastric conditions affect phage viability, thereby reducing their effectiveness. In this study, alginate (ALG)/κ-carrageenan (CG) microcapsules were developed to encapsulate and release phage under simulated gastrointestinal conditions. The effects of ALG and CG concentrations on the encapsulation and loading effi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 36 publications
1
9
0
Order By: Relevance
“…As pH values reach 5.5 and above, the alginic acid dissolves and the alginate disassociates [10,16]. Previous studies have exploited this pH-dependent solubility of pure alginate, and modified alginate gels like those formulated in this study to demonstrate the successful survival of phages targeting pathogenic bacteria in simulated gastrointestinal environments [13][14][15]. For this reason, this study focused on the alginate encapsulation of LOCARD, and is the first study to describe such an encapsulation approach for MPs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As pH values reach 5.5 and above, the alginic acid dissolves and the alginate disassociates [10,16]. Previous studies have exploited this pH-dependent solubility of pure alginate, and modified alginate gels like those formulated in this study to demonstrate the successful survival of phages targeting pathogenic bacteria in simulated gastrointestinal environments [13][14][15]. For this reason, this study focused on the alginate encapsulation of LOCARD, and is the first study to describe such an encapsulation approach for MPs.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that phages suspended in alginate matrices-and subsequently encapsulated in alginate gels-could be shielded from the acidic environment of the stomach, and later released into the intestinal environment as the pH gradually increases along the small intestine [11]. This was successfully demonstrated with various formulations of alginate-encapsulated phages (i.e., often containing additional gelling agents, e.g., chitosan [12]) in simulated gastrointestinal environments using phages targeting Escherichia coli, Salmonella enterica, and Listeria monocytogenes [13][14][15]. This study aims to demonstrate similar outcomes with MPs.…”
Section: Introductionmentioning
confidence: 99%
“…Iota-carrageenan is a sulfate hydrocolloid that is widely used in pharmacological, medicinal, and non-food applications. It is derived from seaweed [ 48 ].…”
Section: Natural Polymers Used For Encapsulationmentioning
confidence: 99%
“…The combination of alginate and carrageenan improved phage protection against acidic conditions. In general, the composite microcapsules significantly enhanced phage viability in the gastric environment, although different ratios of alginate and κ-carrageenan showed inconsistent protective efficacy ( Figure 18 ) [ 109 ].…”
Section: Wall Materials: Natural Polymer Coatingsmentioning
confidence: 99%